Heart drug tested in people with kidney problems
NCT ID NCT06775834
Summary
This study examined how HRS-1893, an experimental medication for hypertrophic cardiomyopathy, behaves in people with reduced kidney function compared to healthy people. Researchers measured drug levels in the blood of 24 participants to understand how kidney impairment affects the medication. The goal was to gather information that could help determine appropriate doses for patients with kidney problems.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTROPHIC CARDIOMYOPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sichuan Provincial People's Hospital
Chengdu, Sichuan, 610072, China
Conditions
Explore the condition pages connected to this study.